Beam Therapeutics Inc
(MEX:BEAM)
MXN
450
0 (0%)
Market Cap: 34.68 Bil
Enterprise Value: 17.67 Bil
PE Ratio: 0
PB Ratio: 2.07
GF Score: 38/100 - Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Beam Therapeutics Inc at Citi BioPharma Conference TranscriptSep 07, 2023
- Beam Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Beam Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2023
- Beam Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Beam Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Beam Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Beam Therapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Beam Therapeutics Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Beam Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Beam Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 27, 2021
- Beam Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Beam Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript
Oct 27, 2021 / 08:00PM GMT
Michael Yee
(Trades, Portfolio) LLC - Analyst
All right. Well, good afternoon and thank you for joining us on another great session here at the Jefferies virtual Gene Therapy and Gene Editing Summit. We've had a great day so far. A lot of great firesides as well with some folks who are quite familiar with our guest here on this session, Beam Therapeutics. And I was just talking with John about how David Liu had some very nice comments earlier today about where the space is going.
I wanted to, of course, introduce the CEO of Beam Therapeutics, John Evans, here with us. He has been making some great progress along single base pair gene editing, which is a next-generation technology.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)